This document provides healthcare practitioners with information regarding the
management of acute rhinosinusitis (ARS) and chronic rhinosinusitis (CRS) to enable them …

Moxifloxacin, a fluoroquinolone with potent activity against respiratory pathogens, is
approved and considered as an alternative to β-lactams and macrolides for the treatment of …

Evidence-based guidelines for the diagnosis and initial management of suspected acute
bacterial rhinosinusitis in adults and children were prepared by a multidisciplinary expert …

The main objectives of this study were to estimate the frequency of chronic maxillary sinusitis
of dental origin, and to evaluate the microbiology of odontogenic and non-odontogenic …

Background Sinusitis is one of the most common diagnoses among adults in ambulatory
care, accounting for 15% to 21% of all adult outpatient antibiotic prescriptions. However, the …

Objectives/Hypothesis To systematically assess the prevalence of bacterial infection in
adults with acute rhinosinusitis (ARS). Methods Electronic databases were systematically …

Background: The presumed superiority of newer fluoroquinolones for the treatment of acute
bacterial sinusitis is based on laboratory data but has not yet been established on clinical …

Аннотация Амоксициллин/клавулановая кислота (АМК)–один из препаратов выбора в
лечении инфекций нижних дыхательных путей (ИНДП) у взрослых. Одной из …

Moxifloxacin (MXF) is the latest broad-spectrum fluoroquinolone marketed worldwide. It has
in vitro activity against a wide range of Gram-positive and Gram-negative pathogens …

As antibiotic resistance is increasing worldwide, it is important to prescribe fluoroquinolone
(FQ) antibiotics appropriately for a given infection to preserve class efficacy. Clinical studies …